benefits

Chirpley Joins NVIDIA Inception

  Chirpley, Amsterdam, March 20th— Chirpley today announced it has joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technological advancements. Chirpley is the world’s first automated peer-to-peer, all-in-one influencer marketplace specifically focused on nano and micro influencers. Chirpley focused on leveraging AI technologies to provide tailored matchmaking for brands and influencers, ensuring efficiency, fair evaluation, and data-driven approach to maximize the reach of marketing incentives. Chirpley plans to use the resources available through NVIDIA Inception, including utilizing NVIDIA most advanced technology assistance and top-notch expertise in AI

Life DeFi Partners with Alvara Protocol to Integrate ERC 7621 Basket Token Standard

[Seychelles] — In a significant stride towards enhancing DeFi accessibility and functionality, Life DeFi is thrilled to announce a partnership with Alvara Protocol. This collaboration marks the integration of the innovative ERC 7621 standard into Life DeFi’s mobile and Chrome extension wallets, setting a new standard in the DeFi ecosystem. Alvara Protocol introduces a novel approach to managing and investing in digital assets. By allowing users to create, manage, and trade baskets of tokens, it simplifies the investment process, offering a diversified approach directly within Life DeFi’s platforms. Streamlining DeFi

Hard Forks, Soft Forks, Defaults and Coercion

One of the important arguments in the blockchain space is that of whether hard forks or soft forks are the preferred protocol upgrade mechanism. The basic difference between the two is that soft forks change the rules of a protocol by strictly reducing the set of transactions that is valid, so nodes following the old rules will still get on the new chain (provided that the majority of miners/validators implements the fork), whereas hard forks allow previously invalid transactions and blocks to become valid, so clients must upgrade their clients

Bozo.Finance. A Groundbreaking NFTxTOKEN Solution Revolutionizing Decentralized Finance.

  Bozo.Finance / Bozo Hybrid In an innovative leap forward for the DeFi space, Bozo Hybrid announces the launch of its revolutionary platform - a first-of-its-kind NFTxTOKEN hybrid that is reshaping the landscape of liquidity and asset interchangeability. The Game-Changing Innovation of Bozo HYBRID Bozo HYBRID is not just another project in the blockchain space. It represents a paradigm shift, a true DeFi 2.0 model, by integrating non-fungible tokens (NFTs) with fungible tokens ($bozo tokens) to create a two-way liquidity portal. This hybrid approach is a breakthrough in the market,

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Skale x Cryptopia Making Free-to-play-and-earn A Reality For Gamers

Nov 21, 2023. Tortola, British Virgin Islands. With great excitement, we are pleased to announce our partnership with Skale, a zero-gas fee EVM blockchain. As a pioneering free-to-play-and-earn game that embodies the spirit of a new era in gaming, this alliance is set to transform the gaming landscape by empowering players to combine fun and earning opportunities without the constraints of excessive fees or financial barriers. We are living in exciting times. Gradually, we are entering an era where games are not only for fun but also offer a seamless

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

BANTgo and Verofax Team Up to Revolutionize E-waste Collection Through Tokenized Rewards

DUBAI, Oct 24, 2023 - (ACN Newswire) - In an ambitious stride towards environmental sustainability, BANTgo and Verofax have announced a pioneering collaboration to enhance e-waste collection. The groundbreaking partnership seeks to galvanize the masses into responsible recycling by rewarding their endeavors with tokenized incentives. Verofax, was awarded the GITEX Supernova Web3 and Blockchain award, introduces its innovative technology to this eco-initiative. The venture encompasses the deployment of advanced smart bins explicitly designed for e-waste collection. These bins are equipped with a validation system to ensure accurate assessment of the

Revolutionizing Tourism with Web3: A Landmark Partnership Between Camino Network, DCM Swiss, 1World Online, and Web3-Solutions

In an unprecedented-opportunity-driven move, four innovative companies in the travel and marketing sectors — Camino Network, initiated by Chain4Travel, DCM Swiss, 1World Online, and Web3-Solutions — have come together to announce a landmark partnership. This alliance aims to harness cutting-edge technologies in reshaping the future of travel and tourism experiences and bringing new monetization options and benefits to all ecosystem participants. We are happy to announce that: DCM Swiss and 1World Online are becoming Validators at Camino Network. Web3-Solutions becomes a Regional Partner of DCM: A regional partnership agreement has

Zumo first to launch platform built to meet the tech requirements of the FCA’s new Financial Promotions Regime for Crypto Assets

  The award-winning platform has set a new benchmark in consumer protection and regulatory alignment With some UK operators having to pause activity, Zumo’s financial promotions technical flow is now also available through its B2B API to support unregistered firms with remaining compliant after the 8 October deadline [London/Edinburgh - Friday 29 September 2023] Zumo, the UK-based digital-asset-as-a-service platform, has announced a significant industry milestone as it becomes the first digital asset platform to have integrated tech based requirements of the Financial Conduct Authority’s (FCA’s) new financial promotions regime for

HealthCare AI: The Unavoidable Revolution in Modern Medicine

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are